COMP <GO>
ETON vs GHRS // RSI-14 & 200D SMA MOMENTUM
Eton Pharmaceuticals Inc. (NASDAQ) VS. GH Research PLC (NASDAQ) • 15-METRIC TALLY: ETON 1
— GHRS 1
▲ RSI-14 & 200D SMA MOMENTUM LEADER: GHRS
LAST: $53.67 (+3.61%) • MKT CAP: $1.53B
rsi-technicals
47.9
LAST: $21.50 (+3.82%) • MKT CAP: $1.47B
rsi-technicals
48.0
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ETON VS. GHRS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ETON | GHRS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 53.50% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -0.90% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.66% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -1.10% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -5.80% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 104.90% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 13.37 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 47.9 | 48.0 | -0.07 | GHRS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.53B | $1.47B | $60.1M | ETON | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ETON REV | GHRS REV | ETON GROSS % | GHRS GROSS % | ETON FCF | GHRS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $80.0M | — | 53.5% | — | $10.2M | — |
| FY 2024 | $39.0M | — | 60.0% | — | $943.0K | — |
| FY 2023 | $31.6M | — | — | — | $6.8M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ETON // BETA —
GHRS // BETA —